APOE and dementia: Each additional CMP location was associated with a higher dementia risk in APOE ɛ4 carriers (HR, 1.13, 95% CI: 1.09–1.17) compared to non-carriers (HR, 1.07, 95% CI: 1.03–1.11; Figure 1).